{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-062900","form_type":"8-K","ticker":"MRAI","cik":"0001844392","company_name":"Marpai, Inc.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.986412+00:00","generated_at":"2026-06-08T05:27:38.633046+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Marpai Q3 revenue $8.7M (+77% YoY); net loss $7.3M; withdraws S-1, suspends guidance","bullets":["Total revenue $8.7M for Q3 2023, up 77% YoY, driven by acquisition of Maestro Health.","Net loss of $7.3M ($0.98 per share) vs. net loss $5.8M ($1.14 per share) in Q3 2022.","Customers' employees reached ~37,000, a 126% increase from 16,000 a year ago.","Withdrew its Form S-1 registration statement due to adverse market conditions; evaluating financing.","Suspended full-year 2023 financial guidance; company focusing on path to profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-062900","json":"https://secwatch.observer/filing/0000950170-23-062900.json","markdown":"https://secwatch.observer/filing/0000950170-23-062900.md","text":"https://secwatch.observer/filing/0000950170-23-062900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023062900/0000950170-23-062900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023062900/mrai-20231113.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T05:27:38.633046+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e82e87166db4fbe5ec29c865b9034e0885a58534","claim":"Marpai, Inc. reported three and nine months ended September 30, 2023 results: revenue $8.7 million, net income nearly $7.3 million, EPS ($0.98) per share.","evidence_excerpt":"Health, LLC (“Maestro Health”) since its acquisition on November 1, 2022. Third Quarter 2023 Highlights: • Total revenue for the three months ended September 30, 2023 was $8.7 million, representing an increase of $3.8 million, or nearly 77%, over the same period in 2022. The primary reason for this increase was due to the revenue from the acquisition of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023062900/0000950170-23-062900-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three and nine months ended September 30, 2023"},{"label":"Revenue","value":"$8.7 million"},{"label":"Net income","value":"nearly $7.3 million"},{"label":"EPS","value":"($0.98) per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}